Ecoza
- Generic Name: econazole nitrate topical foam, 1%
- Brand Name: Ecoza
Ecoza (Econazole Nitrate Topical Foam, 1%) side effects drug center
- Related Drugs
- Drug Comparison
- application site reactions such as burning, stinging, itching, or redness of the skin
- warfarin
- burning, itching, stinging, and redness.
What Is Ecoza?
Ecoza (econazole nitrate) Topical Foam is an azole antifungal used to treat a fungal infection of the feet, commonly called athlete's foot (interdigital tinea pedis) caused by Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.
What Are Side Effects of Ecoza?
Common side effects of Ecoza include:
Dosage for Ecoza
Each gram of Ecoza topical foam, 1%, contains a dose of 10 mg of econazole nitrate, which is applied to cover the affected areas once daily for 4 weeks.
What Drugs, Substances, or Supplements Interact with Ecoza?
Ecoza may interact with other medicines such as:
Tell your doctor all medications and supplements you use.
Ecoza During Pregnancy and Breastfeeding
Ecoza may interact with warfarin. Tell your doctor all medications and supplements you use. During pregnancy, Ecoza should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Additional Information
Our Ecoza (econazole nitrate) Topical Foam Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have severe burning, redness, or stinging after applying the medicine.
Common side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Ecoza (Econazole Nitrate Topical Foam, 1%)
SIDE EFFECTS
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In two double-blind, vehicle-controlled clinical trials, 495 subjects were exposed to Ecoza topical foam or vehicle (246 subjects were exposed to Ecoza topical foam, 1% and 249 were exposed to vehicle). Subjects with interdigital tinea pedis applied foam or vehicle once daily for approximately 28 days. During clinical trials with Ecoza topical foam, the most common adverse reactions were application site reactions which occurred in less than 1% of subjects in both the Ecoza and vehicle arms.
DRUG INTERACTIONS
Warfarin
Concomitant administration of econazole and warfarin has resulted in enhancement of anticoagulant effect. Most cases reported product application with use under occlusion, genital application, or application to a large body surface area which may increase the systemic absorption of econazole nitrate. Monitoring of International Normalized Ratio (INR) and/or prothrombin time may be indicated especially for patients who apply econazole to large body surface areas, in the genital area, or under occlusion.
Read the entire FDA prescribing information for Ecoza (Econazole Nitrate Topical Foam, 1%)
© Ecoza Patient Information is supplied by Cerner Multum, Inc. and Ecoza Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.